A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
about
Choline: critical role during fetal development and dietary requirements in adultsProtective Effects of Dietary Supplementation with a Combination of Nutrients in a Transgenic Mouse Model of Alzheimer's DiseaseRole of aqueous extract of Azadirachta indica leaves in an experimental model of Alzheimer's disease in ratsPhospholipids do not have lipolytic activity. A critical review.Complementary and alternative medicines for Alzheimer's disease.Neurotransmitter replacement therapy in Alzheimer's disease.Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints.Correlates of response to acetylcholinesterase inhibitor therapy in Alzheimer's disease.Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.Dietary choline and betaine intakes and risk of cardiovascular diseases: review of epidemiological evidence.Cholinergic and glutamatergic drugs in Alzheimer's disease therapy.Recent advances in the understanding of dementiaDietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study.Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.Oral choline supplementation for postoperative pain.Pharmacosomes: the lipid-based new drug delivery system.Choline and betaine in health and disease.The effects of dietary choline.Mesotherapy for local fat reduction.Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis.Tetrahydroaminoacridine (THA) in Alzheimer's disease.Critical review of clinical trials in senile dementia--II.The cholinergic neurotransmitter system in human memory and dementia: a review.Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.Are drugs targeted at Alzheimer's disease useful? 1. Useful for what?Pharmacotherapy of cognitive impairment in Alzheimer's disease: a review.[Relations between specific neurochemical systems and memory: problems posed by dementia of the Alzheimer type]Neuropsychiatric development: two case reports about the use of dietary fish oils and/or choline supplementation in children.Twenty years of cholinergic intervention in Alzheimer's disease: A tale of disappointment and ultimate confidence.Tacrine and lecithin in Alzheimer's disease.The treatment of Alzheimer's diseaseCholinergic effects on constructional abilities and on mnemonic processes: a case report
P2860
Q24649101-7AAAB4B6-51AF-490B-89FE-857087E4D7D6Q28551173-888B2815-6D9C-4788-99AA-EB880AB3E931Q30453444-249F228D-4213-4B09-BAC8-6B815EA99B35Q33345430-CB5B9842-BE30-4AF6-9099-27D96AF97344Q33609573-C5E252AD-0D7D-4751-B7BF-69047A2E0A5EQ33921314-38161116-D55B-48A6-A147-6F9ED1E4A7E4Q34255281-0E229C77-2F47-43E7-B668-3D916255915FQ35066849-E7449D2E-EDF4-453B-ACAA-48D6145AA066Q35168053-06F8562C-E0C5-44D9-A729-26C545D0C0AFQ35945281-910F7896-424B-4AF7-A1E2-C71CFE16DAB3Q36257227-EA8644B9-40DF-41B0-A8E6-F360A810DCAEQ36722253-36380F05-4A88-45EB-BB2B-A63AEAD10F9AQ36726727-A48E4077-CB2A-4573-8020-3AA4D786BEF6Q36884943-D4CA6BA4-9DA7-4B9F-9D4C-8B110D130EE5Q37345030-C7C2434B-3B08-4AC6-A8FD-0547BB3EE64DQ37515443-0B620011-02F2-4525-BC82-6CC5694FB454Q37743322-7C20F3DB-B8C4-4A49-974D-55813DC7397FQ37936218-C387639B-B92E-4386-B917-D261542F14D9Q38116980-2B1AB9CB-FB82-4362-8A69-14709C3D7921Q38218602-467AEE92-AEAF-4E16-902D-5035CD8D11FBQ38224587-8AC07EE4-56E3-40B2-B2EC-492F2D391E5DQ39173624-ABD05A8E-9EA6-4E83-950F-7109DC93612CQ39756011-3921A290-1B29-400D-A0A5-6BD54B4E2876Q39916503-0E7AC97C-1597-4410-A235-3BB7705B9C52Q39916654-015396FA-400C-42ED-8B10-16AA3DB34B2FQ40552135-420A562E-B28B-432D-815C-35DC0118E485Q42555682-FEE7E9E2-DD97-4724-95B1-4E221EB958BAQ52035990-CCB2FE35-A28B-407A-B625-8A6B87CB40D1Q52041002-DE3A03B0-A117-4C6C-8A14-F956D749DAA4Q55004326-071BF4EB-F748-40A8-AA1C-8D2B4BE2E9A4Q57526641-5CFB3CA3-576B-487A-86E3-C7D5D8244229Q57913275-5ADE63C2-B59C-4DC4-B867-5BB3F5119B83
P2860
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
description
1985 nî lūn-bûn
@nan
1985 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
@ast
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
@en
type
label
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
@ast
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
@en
prefLabel
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
@ast
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
@en
P2093
P2860
P356
P1476
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.
@en
P2093
P2860
P304
P356
10.1136/JNNP.48.8.736
P407
P577
1985-08-01T00:00:00Z